{"id":7781,"date":"2022-08-30T12:22:40","date_gmt":"2022-08-30T12:22:40","guid":{"rendered":"http:\/\/staging.grindeks.eu\/?p=7781"},"modified":"2022-09-06T13:11:45","modified_gmt":"2022-09-06T13:11:45","slug":"grindeks-paplasina-patentbrivo-medikamentu-klastu-un-darbibu-starptautiskos-tirgos","status":"publish","type":"post","link":"https:\/\/grindeks.com\/lv\/grindeks-paplasina-patentbrivo-medikamentu-klastu-un-darbibu-starptautiskos-tirgos\/","title":{"rendered":"Grindeks papla\u0161ina patentbr\u012bvo medikamentu kl\u0101stu un darb\u012bbu starptautiskos tirgos"},"content":{"rendered":"\n<p>Grindeks, Baltijas valstu vado\u0161ais farm\u0101cijas uz\u0146\u0113mums pazi\u0146o par saviem m\u0113r\u0137iem b\u016btiski papla\u0161in\u0101t patentbr\u012bvo medikamentu kl\u0101stu un darb\u012bbu starptautiskos tirgos.<\/p>\n\n\n\n<p>Grindeks uzskata, ka tam ir milz\u012bgs potenci\u0101ls palielin\u0101t pacientu piek\u013cuvi kvalitat\u012bv\u0101m un efekt\u012bv\u0101m z\u0101l\u0113m \u0101rstniec\u012bb\u0101 svar\u012bg\u0101s terapeitiskaj\u0101s grup\u0101s \u2013 CNS, sirds un asinsvadu, diab\u0113ta un onkolo\u0123isko slim\u012bbu \u0101rst\u0113\u0161anai. Turkl\u0101t Grindeks meitasuz\u0146\u0113mums Kalceks sevi ir p\u0101rliecino\u0161i pieteicis glob\u0101l\u0101 konkurenc\u0113 slimn\u012bcu segment\u0101.<\/p>\n\n\n\n<p>Koncerns p\u0113d\u0113jos gados strauji aug un ir p\u0101rliecin\u0101ts, ka at\u0161\u0137ir\u012bb\u0101 no pasaules farm\u0101cijas tirgus l\u012bderiem, tas sp\u0113j \u0101tri un elast\u012bgi rea\u0123\u0113t uz pacientu vajadz\u012bb\u0101m un piepras\u012bjumu. Uz\u0146\u0113mumos norit z\u0101\u013cu izstr\u0101des procesi, zin\u0101\u0161anu p\u0101rnese un past\u0101v\u012bga infrastrukt\u016bras att\u012bst\u012bba, lai papla\u0161in\u0101tu patentbr\u012bvo produktu portfeli.<\/p>\n\n\n\n<p>2022. gad\u0101 Grindeks pl\u0101no re\u0123istr\u0101cijai iesniegt 18 patentbr\u012bvos medikamentus. Savuk\u0101rt meitasuz\u0146\u0113mums Kalceks re\u0123istr\u0101cijai iesniegs 10 medikamentus slimn\u012bcu segmentam.<\/p>\n\n\n\n<p>Koncernam ir \u013coti noz\u012bm\u012bga akt\u012bvo farmaceitisko vielu ra\u017eo\u0161ana, jo t\u0101 ir viena no koncerna konkurences priek\u0161roc\u012bb\u0101m, kas palielina neatkar\u012bbu no izejvielu ra\u017eot\u0101jiem. Uz\u0146\u0113mums ra\u017eo 25 akt\u012bv\u0101s farmaceitisk\u0101s vielas, un p\u0113c t\u0101m ir liels piepras\u012bjums. Izstr\u0101d\u0113 atrodas 46 jaunas akt\u012bv\u0101s farmaceitisk\u0101s vielas.<\/p>\n\n\n\n<p>Lai nodro\u0161in\u0101tu Grindeks un Kalceks medikamentu pieejam\u012bbu pacientiem, koncerns att\u012bsta savu darb\u012bbu pasaul\u0113. P\u0113rn Grindeks produkcija tika eksport\u0113ta uz 103 pasaules valst\u012bm. L\u012bdztekus jau eso\u0161aj\u0101m p\u0101rst\u0101vniec\u012bb\u0101m un meitasuz\u0146\u0113mumiem, \u0161ogad meitasuz\u0146\u0113mumi tiek atv\u0113rti ASV, \u0160veic\u0113 un vairak\u0101s Eiropas Savien\u012bbas valst\u012bs.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Grindeks valdes priek\u0161s\u0113d\u0113t\u0101js Dr. chem. Juris Hme\u013c\u0146ickis:&nbsp;<\/strong>\u201cViss ir sasniedzams, ja uz\u0146\u0113mums str\u0101d\u0101 ar p\u0101rliec\u012bbu, priek\u0161pl\u0101n\u0101 izvirzot pacientu vajadz\u012bbas. Grindeks komanda ir pier\u0101d\u012bjusi savas sp\u0113jas vienoti iet uz m\u0113r\u0137i. M\u016bs raksturo apzi\u0146a, ka dar\u0101m kaut ko \u012bpa\u0161i svar\u012bgu cilv\u0113ces vesel\u012bbai. Tas ir aicin\u0101jums pal\u012bdz\u0113t cilv\u0113kiem. Turkl\u0101t esam drosm\u012bgi, zino\u0161i un ar pieredzi. Grindeks patentbr\u012bvo medikamentu kl\u0101sta un darb\u012bbas papla\u0161in\u0101\u0161ana b\u016bs \u013coti liels ieguvums pacientiem, jo z\u0101les k\u013c\u016bs tiem pieejam\u0101kas.\u201d<\/p><\/blockquote>\n\n\n\n<p><a href=\"https:\/\/grindeks.lv\/lv\/raksti\/jaunumi\/\" target=\"_blank\" rel=\"noopener\"><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Grindeks, Baltijas valstu vado\u0161ais farm\u0101cijas uz\u0146\u0113mums pazi\u0146o par saviem m\u0113r\u0137iem b\u016btiski papla\u0161in\u0101t patentbr\u012bvo medikamentu kl\u0101stu un darb\u012bbu starptautiskos tirgos. Grindeks uzskata, ka tam ir milz\u012bgs&#8230;<\/p>\n","protected":false},"author":6,"featured_media":7467,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-7781","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/7781","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=7781"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/7781\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/7467"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=7781"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=7781"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=7781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}